TG and differentiated thyroid carcinoma: The thyroid stimulating hormone (TSH)-stimulated serum thyroglobulin (Tg) is a useful biomarker to predict residual or recurrent disease in patients with differentiated thyroid carcinoma (DTC) after total thyroidectomy and radioactive iodine (RAI) therapy [1,2,3,4,5].